Back
4D Molecular Therapeutics Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
11
FDMT
4D Molecular Therapeutics
Last Price:
11.61
Seasonality Move:
44.72%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.4D Molecular Therapeutics Price Quote
$11.61
-0.29 (-14%)
(Updated: September 21, 2024 at 5:10 AM ET)
4D Molecular Therapeutics Key Stats
Sell
11
4D Molecular Therapeutics (FDMT)
is a Sell
Day range:
$11.85 - $13.59
52-week range:
$9.44 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.91
P/B ratio:
1.05%
Volume:
1.7M
Avg. volume:
630.7K
1-year change:
-17.93%
Market cap:
$618.4M
Revenue:
$20.7M
EPS:
$-2.3
How Much Does 4D Molecular Therapeutics Make?
-
How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M -
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M
Is 4D Molecular Therapeutics Growing As A Company?
-
What Is 4D Molecular Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.98% -
What Is 4D Molecular Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
4D Molecular Therapeutics Stock Price Performance
-
Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went down by -22.32% last month -
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price fell by -17.93% over the past 1 year
What Is 4D Molecular Therapeutics 52-Week High & Low?
-
What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks -
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $9.44 over the past 52 weeks
4D Molecular Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy 4D Molecular Therapeutics?
-
How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $541.9M -
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 11.33
Is 4D Molecular Therapeutics Cash Flow Positive?
-
What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$85.2M -
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $351.4M -
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$313.5M
4D Molecular Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FDMT return on invested capital is -25.54% -
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -23.85% -
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -25.54%
4D Molecular Therapeutics Earnings Date & Stock Price
-
What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 11.90 -
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT -
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on November 8, 2024 -
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is September 21, 2024 -
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
4D Molecular Therapeutics Competitors
-
Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
4D Molecular Therapeutics Dividend Yield
-
What Is FDMT Dividend Yield?
4D Molecular Therapeutics’s dividend yield currently is 0% -
What Is 4D Molecular Therapeutics’s Payout Ratio?
4D Molecular Therapeutics’s payout ratio is 0% -
When Did 4D Molecular Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is 4D Molecular Therapeutics’s Dividend Per Share?
4D Molecular Therapeutics pays a dividend of $0.00 per share
4D Molecular Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 10.99% |
| Revenue: | -97.91% | -99.27% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 50.00 |
| Upside from Last Price: | 320.17% |